U.S. In-vitro Fertilization Microscope Market Size, Share & Trends Analysis Report By End-use (Clinical, Academic Research), And Segment Forecast, 2024 - 2030
This report can be delivered to the clients within 3 Business Days
U.S. In-vitro Fertilization Microscope Market Growth & Trends
The U.S. In-vitro fertilization microscope market size is anticipated to reach USD 41.4 million by 2030, registering a CAGR of 7.62% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increasing demand for fertility treatments and the growing focus on the precision & accuracy of fertility procedures are the major factors contributing to market growth. Advancements in microscopy technology have significantly improved the efficiency and success rates of in-vitro fertilization (IVF) procedures. Cutting-edge features lead to enhanced visualization of gametes and embryos, driving market growth. Moreover, the overall growth and expansion of healthcare infrastructure in the U.S. contributed to the demand for IVF microscopes.
As healthcare facilities upgrade their equipment and facilities to meet increasing patient needs, there is a parallel investment in state-of-the-art microscopy systems for IVF labs. The growing number of fertility clinics in the U.S. is another factor driving the demand for IVF microscopes. As more fertility clinics are established, there is a corresponding increase in the demand for advanced IVF equipment, including microscopes. Furthermore, favorable government initiatives and policies promoting IVF procedures and infertility treatments have contributed to market growth. The government promotes grants, such as Baby Quest, Footsteps for Fertility, and Parental Hope Family Grants.
U.S. In-vitro Fertilization Microscope Market Report Highlights
U.S. In-vitro Fertilization Microscope Market Growth & Trends
The U.S. In-vitro fertilization microscope market size is anticipated to reach USD 41.4 million by 2030, registering a CAGR of 7.62% from 2024 to 2030, according to a new report by Grand View Research, Inc. The increasing demand for fertility treatments and the growing focus on the precision & accuracy of fertility procedures are the major factors contributing to market growth. Advancements in microscopy technology have significantly improved the efficiency and success rates of in-vitro fertilization (IVF) procedures. Cutting-edge features lead to enhanced visualization of gametes and embryos, driving market growth. Moreover, the overall growth and expansion of healthcare infrastructure in the U.S. contributed to the demand for IVF microscopes.
As healthcare facilities upgrade their equipment and facilities to meet increasing patient needs, there is a parallel investment in state-of-the-art microscopy systems for IVF labs. The growing number of fertility clinics in the U.S. is another factor driving the demand for IVF microscopes. As more fertility clinics are established, there is a corresponding increase in the demand for advanced IVF equipment, including microscopes. Furthermore, favorable government initiatives and policies promoting IVF procedures and infertility treatments have contributed to market growth. The government promotes grants, such as Baby Quest, Footsteps for Fertility, and Parental Hope Family Grants.
U.S. In-vitro Fertilization Microscope Market Report Highlights
- The clinical sector dominated the end-use segment with a share of 93.8% in 2023 and is anticipated to witness the fastest CAGR from 2024 to 2030
- This can be attributed to the technological advancements in fertility treatments & procedures and a rise in demand for assisted reproduction technology
- In December 2023, Hamilton Thorne announced the acquisition of MICROPTIC, a developer of artificial intelligence (AI)-enabled CASA software, image analysis systems, and consumables for the Assisted Reproductive Technology laboratory markets worldwide
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. End-use
1.2.2. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Volume price analysis (Model 2)
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. End-use outlook
2.3. Competitive Insights
CHAPTER 3. U.S. IN-VITRO FERTILIZATION MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. U.S. In-Vitro Fertilization Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic Landscape
CHAPTER 4. U.S. IN-VITRO FERTILIZATION MARKET: END-USE ESTIMATES & TREND ANALYSIS
4.1. End-use Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. U.S. In-Vitro Fertilization Market by End-use Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
4.4.1. Clinical
4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. Academic Research
4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 5. COMPETITIVE LANDSCAPE
5.1. Recent Developments & Impact Analysis, By Key Market Participants
5.2. Company/Competition Categorization
5.3. Vendor Landscape
5.3.1. List of key distributors and channel partners
5.3.2. Key customers
5.3.3. Key company heat map analysis, 2023
5.4. Company Profiles
5.4.1. Leica Microsystems
5.4.1.1. Company overview
5.4.1.2. Financial performance
5.4.1.3. Product benchmarking
5.4.1.4. Strategic initiatives
5.4.2. Olympus Corporation
5.4.2.1. Company overview
5.4.2.2. Financial performance
5.4.2.3. Product benchmarking
5.4.2.4. Strategic initiatives
5.4.3. Nikon Corporation
5.4.3.1. Company overview
5.4.3.2. Financial performance
5.4.3.3. Product benchmarking
5.4.3.4. Strategic initiatives
5.4.4. Sutter Instrument Company
5.4.4.1. Company overview
5.4.4.2. Financial performance
5.4.4.3. Product benchmarking
5.4.4.4. Strategic initiatives
5.4.5. Hamilton Thorne
5.4.5.1. Company overview
5.4.5.2. Financial performance
5.4.5.3. Product benchmarking
5.4.5.4. Strategic initiatives
5.4.6. Zeiss
5.4.6.1. Company overview
5.4.6.2. Financial performance
5.4.6.3. Product benchmarking
5.4.6.4. Strategic initiatives
5.4.7. Meiji Techno
5.4.7.1. Company overview
5.4.7.2. Financial performance
5.4.7.3. Product benchmarking
5.4.7.4. Strategic initiatives
5.4.8. Labomed, Inc.
5.4.8.1. Company overview
5.4.8.2. Financial performance
5.4.8.3. Product benchmarking
5.4.8.4. Strategic initiatives
5.4.9. Narishige Group
5.4.9.1. Company overview
5.4.9.2. Financial performance
5.4.9.3. Product benchmarking
5.4.9.4. Strategic initiatives
5.4.10. Eppendorf SE
5.4.10.1. Company overview
5.4.10.2. Financial performance
5.4.10.3. Product benchmarking
5.4.10.4. Strategic initiatives
5.4.11. Tritech Research, Inc.
5.4.11.1. Company overview
5.4.11.2. Financial performance
5.4.11.3. Product benchmarking
5.4.11.4. Strategic initiatives
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. End-use
1.2.2. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Volume price analysis (Model 2)
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. End-use outlook
2.3. Competitive Insights
CHAPTER 3. U.S. IN-VITRO FERTILIZATION MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. U.S. In-Vitro Fertilization Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic Landscape
CHAPTER 4. U.S. IN-VITRO FERTILIZATION MARKET: END-USE ESTIMATES & TREND ANALYSIS
4.1. End-use Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. U.S. In-Vitro Fertilization Market by End-use Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
4.4.1. Clinical
4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.4.2. Academic Research
4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
CHAPTER 5. COMPETITIVE LANDSCAPE
5.1. Recent Developments & Impact Analysis, By Key Market Participants
5.2. Company/Competition Categorization
5.3. Vendor Landscape
5.3.1. List of key distributors and channel partners
5.3.2. Key customers
5.3.3. Key company heat map analysis, 2023
5.4. Company Profiles
5.4.1. Leica Microsystems
5.4.1.1. Company overview
5.4.1.2. Financial performance
5.4.1.3. Product benchmarking
5.4.1.4. Strategic initiatives
5.4.2. Olympus Corporation
5.4.2.1. Company overview
5.4.2.2. Financial performance
5.4.2.3. Product benchmarking
5.4.2.4. Strategic initiatives
5.4.3. Nikon Corporation
5.4.3.1. Company overview
5.4.3.2. Financial performance
5.4.3.3. Product benchmarking
5.4.3.4. Strategic initiatives
5.4.4. Sutter Instrument Company
5.4.4.1. Company overview
5.4.4.2. Financial performance
5.4.4.3. Product benchmarking
5.4.4.4. Strategic initiatives
5.4.5. Hamilton Thorne
5.4.5.1. Company overview
5.4.5.2. Financial performance
5.4.5.3. Product benchmarking
5.4.5.4. Strategic initiatives
5.4.6. Zeiss
5.4.6.1. Company overview
5.4.6.2. Financial performance
5.4.6.3. Product benchmarking
5.4.6.4. Strategic initiatives
5.4.7. Meiji Techno
5.4.7.1. Company overview
5.4.7.2. Financial performance
5.4.7.3. Product benchmarking
5.4.7.4. Strategic initiatives
5.4.8. Labomed, Inc.
5.4.8.1. Company overview
5.4.8.2. Financial performance
5.4.8.3. Product benchmarking
5.4.8.4. Strategic initiatives
5.4.9. Narishige Group
5.4.9.1. Company overview
5.4.9.2. Financial performance
5.4.9.3. Product benchmarking
5.4.9.4. Strategic initiatives
5.4.10. Eppendorf SE
5.4.10.1. Company overview
5.4.10.2. Financial performance
5.4.10.3. Product benchmarking
5.4.10.4. Strategic initiatives
5.4.11. Tritech Research, Inc.
5.4.11.1. Company overview
5.4.11.2. Financial performance
5.4.11.3. Product benchmarking
5.4.11.4. Strategic initiatives
LIST OF TABLES
Table 1 List of abbreviations
Table 2 U.S. in-vitro fertilization market, by end-use, 2018 - 2030 (USD Million)
Table 1 List of abbreviations
Table 2 U.S. in-vitro fertilization market, by end-use, 2018 - 2030 (USD Million)
LIST OF FIGURES
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 U.S. in-vitro fertilization market: market outlook
Fig. 10 U.S. in-vitro fertilization competitive insights
Fig. 11 Parent market outlook
Fig. 12 Related/ancillary market outlook
Fig. 13 Penetration and growth prospect mapping
Fig. 14 Industry value chain analysis
Fig. 15 U.S. in-vitro fertilization market driver impact
Fig. 16 U.S. in-vitro fertilization market restraint impact
Fig. 17 U.S. in-vitro fertilization market strategic initiatives analysis
Fig. 18 U.S. in-vitro fertilization Market: End-use movement Analysis
Fig. 19 U.S. in-vitro fertilization market: End-use outlook and key takeaways
Fig. 20 Clinical market estimates and forecasts, 2018 - 2030
Fig. 21 Academic research estimates and forecasts, 2018 - 2030
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Primary interviews
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 U.S. in-vitro fertilization market: market outlook
Fig. 10 U.S. in-vitro fertilization competitive insights
Fig. 11 Parent market outlook
Fig. 12 Related/ancillary market outlook
Fig. 13 Penetration and growth prospect mapping
Fig. 14 Industry value chain analysis
Fig. 15 U.S. in-vitro fertilization market driver impact
Fig. 16 U.S. in-vitro fertilization market restraint impact
Fig. 17 U.S. in-vitro fertilization market strategic initiatives analysis
Fig. 18 U.S. in-vitro fertilization Market: End-use movement Analysis
Fig. 19 U.S. in-vitro fertilization market: End-use outlook and key takeaways
Fig. 20 Clinical market estimates and forecasts, 2018 - 2030
Fig. 21 Academic research estimates and forecasts, 2018 - 2030
